Advanced search
Publication Cover
Pathogens and Global Health Volume 107, 2013 - Issue 4
Submit an article Journal homepage
155
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Prevalence of Toxoplasma gondii infection among individuals with severe mental illness in Nigeria: a case control study

Bawo O JamesDepartment of Clinical ServicesFederal Psychiatric Hospital, Uselu, Benin City, Edo State, NigeriaCorrespondence[email protected]
,
Imafidon O AgbonileDepartment of Clinical ServicesFederal Psychiatric Hospital, Uselu, Benin City, Edo State, Nigeria
,
Modupe OkoloDepartment of Clinical ServicesFederal Psychiatric Hospital, Uselu, Benin City, Edo State, Nigeria
,
Ambrose O LawaniDepartment of Clinical ServicesFederal Psychiatric Hospital, Uselu, Benin City, Edo State, Nigeria
&
Joyce O OmoaregbaDepartment of Clinical ServicesFederal Psychiatric Hospital, Uselu, Benin City, Edo State, Nigeria
Pages 189-193 | Received 26 Jul 2012, Accepted 17 Apr 2013, Published online: 03 Dec 2013

References

  • Hamidinejat H, Ghorbanpoor M, Hosseini H, Alavi SM, Nabavi L, Jalali MH, et al.. Toxoplasma gondii infection in first-episode and inpatient individuals with schizophrenia. Int J Infect Dis. 2010;14:e978–81.
  • Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behaviour disorders – overview of evidence and mechanisms. Folia Parasitol. 2010;57(2):105–13.
  • Carruthers VB, Suzuki Y. Effects of Toxoplasma gondii infection on the brain. Schizophr Bull. 2007;33(3):745–51.
  • Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull. 2012;38(3):642–7.
  • Webster JP, Lamberton PH, Donnelly CA, Torrey EF. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood stabilizer and anti-parasite medication on Toxoplasma gondii’s ability to alter host behaviour. Proc Biol Sci. 2006;273(1589):1023–30.
  • Negash T, Tilahun G, Medhin G. Seroprevalence of Toxoplasma gondii in Nazareth Town, Ethiopia. Cent Afr J Med. 2007;53(9–12):47–51.
  • Uneke CJ, Duhlinska DD, Ngwu BA, Njoku MO. Seroprevalence of Toxoplasma gondii infection in Kwal, a rural district of Plateau-Nigeria. Afr J Med Med Sci 2007;36(2):109–13.
  • Kamani J, Mani AU, Egwu GO, Kumushe HA. Seroprevalence studies of human infection with Toxoplasma gondii and the associated risk factors in Maiduguri, Borno State, Nigeria. Ann Trop Med Parasitol. 2009;103(4):317–21.
  • Sheehan DV, Lecrubier Y, Sheehan HK, Amorim P, Janavs J, Weiller E, et al.. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 (Suppl 20):22–33.
  • Adewuya AO, Ologun YA, Ibigbami OS. Post-traumatic stress disorder after childbirth in Nigerian women: prevalence and risk factors. BJOG. 2006;113:284–8.
  • Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF, et al.. Post-traumatic stress disorder (PTSD) after stigma related events in HIV infected individuals in Nigeria. Soc Psychiatry Psychiatr Epidemiol. 2009;44(9):761–6.
  • Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799–812.
  • Ohaeri JU, Otote DI. Subtypes and factors of schizophrenia in an acutely ill Nigerian sample. Psychopathology. 2003;36:181–9.
  • Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 2007;33(3):729–36.
  • Akinbami AA, Adewunmi AA, Rabiu KA, Wright KO, Dosunmu AO, Dada MO, Adeyemo TA. Seroprevalence of Toxoplasma gondii antibodies amongst women at the Lagos State University Teaching Hospital, Nigeria. Niger Postgrad Med J. 2010;17(2):164–7.
  • Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry. 2005;162:767–73.
  • Negash T, Tilahun G, Medhin G. Seroprevalence of Toxoplasma gondii in Nazaret town, Ethiopia. East Afr J Public Health. 2008;5(3):211–4.
  • Shibre T, Alem A, Abdulahi A, Araya M, Beyero T, Medhin G, et al.. Trimethoprim as adjuvant treatment in schizophrenia: a double blind, randomized, placebo-controlled clinical trial. Schizophr Bull. 2010;36 (4):846–51.
  • Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B, et al.. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;25:4–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.